Rectal Cancer and Teaching Hospitals: Hospital Teaching Status Affects Use of Neoadjuvant Radiation and Survival for Rectal Cancer Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
For rectal cancer, it is unknown how use of radiation, treatment cost, and survival differ based on hospital teaching designation.
Private insurance claims data linked with the Pennsylvania Cancer Registry were used to identify rectal cancer patients undergoing surgery from 2004 to 2006. Patients with missing data of interest were excluded. Hospitals were characterized as follows: large (≥200 beds) versus small size (<200 beds), teaching versus nonteaching, and urban versus rural. Logistic regression was used to model the use of neoadjuvant radiotherapy, and Cox proportional hazards models were used to compare cancer-specific survival between hospital types.
A total of 432 patients were analyzed. There was no difference in the distribution of cancer stages among the various hospital types (all p > 0.20). Teaching hospitals were associated with significantly higher utilization of neoadjuvant radiotherapy for stage II and III cancers compared with nonteaching facilities (57 vs. 28 %; p < 0.0001). On multivariate analysis, teaching status was the only hospital designation associated with use of neoadjuvant radiation (p < 0.001); hospital size and rural/urban designation were not significant. Nonteaching hospitals were more likely to use adjuvant radiotherapy for stage II and III disease (13 vs. 30 %; p < 0.01). Teaching hospitals had lower odds of death from rectal cancer when evaluating all stages [hazard ratio (HR) = 0.35; p < 0.0001] with similar costs of inpatient treatment (teaching: US $30,769 versus nonteaching: US $26,892; p = 0.22).
Teaching designation was associated with higher incidence of neoadjuvant radiotherapy for stage II and III disease, with improved cancer-specific survival compared with nonteaching hospitals, and with similar treatment costs.
- Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52. CrossRef
- Borowski DW, Bradburn DM, Mills SJ, Bharathan B, Wilson RG, Ratcliffe AA, et al. Northern Region Colorectal Cancer Audit Group (NORCCAG). Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg. 2010;97:1416–30. CrossRef
- Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg. 1998;228:71–8. CrossRef
- Billingsley KG, Morris AM, Green P, Dominitz JA, Matthews B, Dobie SA, et al. Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection? J Am Coll Surg. 2008;206:1167–77. CrossRef
- Kressner M, Bohe M, Cedermark B, Dahlberg M, Damber L, Lindmark G, et al. The impact of hospital volume on surgical outcome in patients with rectal cancer. Dis Colon Rectum. 2009;52:1542–9. CrossRef
- Harmon JW, Tang DG, Gordon TA, Bowman HM, Choti MA, Kaufman HS, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg. 1999;230:404–11; discussion 411–3.
- Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, et al. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. J Clin Oncol. 2004;22:166–74. CrossRef
- Schrag D, Panageas KS, Riedel E, Cramer LD, Guillem JG, Bach PB, et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg. 2002;236:583–92. CrossRef
- Hodgson DC, Zhang W, Zaslavsky AM, Fuchs CS, Wright WE, Ayanian JZ. Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst. 2003;95:708–16. CrossRef
- National Cancer Center Network (NCCN). http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#rectal. Accessed 15 Jun 2011.
- University of Washington Rural Health Research Center. http://depts.washington.edu/uwrhrc/index.php. Accessed 20 Nov 2011
- American Hospital Directory. Seattle, Washington. http://www.ahd.com/. Accessed 20 Nov 2011
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. CrossRef
- Consumer Price Index. U. S. Bureau of Labor Statistics, Division of Consumer Prices & Price Indexes, Washington. 2011. http://www.bls.gov/cpi/. Accessed 18 Nov 2011
- Rogers SO, Wolf RE, Zaslacsky AM, Wright WE, Ayanian JZ. Relation of surgeon and hospital volume to processes and outcomes of colorectal cancer surgery. Ann Surg. 2006;244:1003–11. CrossRef
- Dimick JB, Cowan JA Jr, Upchurch GR Jr, Colletti LM. Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States. J Surg Res. 2003;114:50–6. CrossRef
- Engel J, Kerr J, Eckel R, Günther B, Heiss M, Heitland W, et al. Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol. 2005;31:512–20. CrossRef
- Marusch F, Koch, Schmidt U, Pross M, Gastinger I, Lippert H. Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg. 2001;88:1397–402. CrossRef
- Matthiessen P, Hallböök O, Rutegård J, Sjödahl R. Population-based study of risk factors postoperative death after anterior resection of the rectum. Br J Surg. 2006;93:498–503. CrossRef
- Engel AF, Oomen JLT, Knol DL, Cuesta MA. Operative mortality after colorectal resection in the Netherlands. Br J Surg. 2005;92;1526–32. CrossRef
- Sauer R, Fietkau R, Wittekind C, Rodel C. Adjuvant vs. neoadjuvant radiotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis. 2002;5:406–15. CrossRef
- Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008–15. CrossRef
- Swedish rectal cancer trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. New Engl J Med. 1997;336:980–7. CrossRef
- Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46. CrossRef
- Wibe A, Carlsen E, Dahl O, Tveit KM, et al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis. 2006;8(3):224–9 CrossRef
- Rectal Cancer and Teaching Hospitals: Hospital Teaching Status Affects Use of Neoadjuvant Radiation and Survival for Rectal Cancer Patients
Annals of Surgical Oncology
Volume 20, Issue 4 , pp 1156-1163
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA, USA
- 2. Department of Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA, USA
- 3. School of Population Health, Thomas Jefferson University, Philadelphia, PA, USA
- 4. Highmark Inc., Pittsburgh, PA, USA
- 5. Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA